GPCR Nanodisc Proteins for Antibody Discovery and Ligand-Binding Assays

GPCR nanodisc proteins provide membrane-mimetic targets for researchers comparing reagents for conformational antibody screening, ELISA, SPR, BLI and ligand-binding assays. The right product depends on the receptor sequence, tag, biotinylation status, documented activity and planned immobilization method. Beta LifeScience offers catalog-listed human GPCR nanodiscs, including A2AR, GPRC5D and biotinylated CXCR4 formats, along with custom nanodisc development for other receptors, species and assay configurations.

Planning a GPCR antibody or ligand-binding study?
Compare the target sequence, nanodisc format, capture tag, documented activity and assay orientation before ordering.

Explore Nanodisc Transmembrane Proteins
Request GPCR Nanodisc Product Matching and a Quote

Products discussed in this guide are for research use. Suitability should be confirmed in the intended assay configuration.

Why Use GPCR Nanodisc Proteins?

G protein-coupled receptors are multi-pass membrane proteins whose extracellular loops, transmembrane helices and lipid environment contribute to their conformation. Experimental evidence shows that membrane lipids can influence GPCR conformational equilibria and signaling-complex formation (Thakur et al., Nature Communications, 2023). A short peptide may reproduce a linear sequence, but it may not display the three-dimensional extracellular epitope recognized by a conformation-sensitive antibody. Detergent-solubilized receptors can be useful, although detergent choice and receptor stability must be evaluated carefully.

Nanodiscs place a membrane protein within a small phospholipid bilayer stabilized by a surrounding scaffold. This creates a soluble particle that can preserve membrane-associated presentation while remaining compatible with biochemical binding workflows. A 2024 review describes nanodiscs as versatile tools for studying membrane proteins and protein–membrane interactions under native-like conditions (Denisov and Sligar, Current Opinion in Structural Biology, 2024).

For commercial selection, the important question is not whether nanodiscs are universally superior. It is whether the planned antibody or ligand recognizes a receptor state and epitope that require full-length, lipid-supported presentation.

Nanodisc binding does not replace every cell-based experiment. It provides a defined biochemical target for screening and characterization; receptor signaling, internalization or functional antagonism generally requires a suitable cellular system.

Featured GPCR Nanodisc Proteins for Antibody and Ligand-Binding Studies

The following catalog-listed products provide practical starting points for technical and purchasing evaluation. Each is available through an online inquiry route, allowing researchers to request current size options, pricing, availability, lead time and supporting documentation.

Numerical activity values are assay-specific and should not be treated as universal performance specifications. Review each current product page for formulation, storage, endotoxin, capture method and complete test conditions. Beta LifeScience can confirm current ordering details and project-specific requirements before purchase. The listed activity data primarily document antibody binding in the stated assay configurations. For native ligands, peptides or small molecules, request ligand-relevant validation information or discuss a project-specific assay configuration before ordering.

Already selected a target?
Open the relevant product page and use its online inquiry form to request available sizes, current pricing, lead time and application documentation.

View A2AR Nanodisc
View GPRC5D Nanodisc
View Biotinylated CXCR4 Nanodisc

Need another GPCR, species or capture format?
Submit the target, accession number, construct requirements, assay platform and preferred tag for catalog comparison or custom nanodisc evaluation.

Request a GPCR Nanodisc Evaluation

How to Select a GPCR Nanodisc Protein for Antibody Discovery

Match the complete receptor sequence

Confirm the species, accession number, isoform and expression range. Two products with the same target symbol may represent different isoforms or sequence boundaries. A full-length construct is useful only if it contains the intended epitope and relevant receptor features. For species cross-reactivity work, do not compare a human nanodisc with a soluble mouse fragment and interpret the difference as species specificity. Align the construct type, sequence coverage, tag and assay orientation as closely as practical.

Select the capture strategy before ordering

His-tagged and biotinylated GPCR nanodiscs support different immobilization routes. A His tag may support compatible Ni-NTA capture or plate-based configurations, but accessibility and scaffold-related background should be assessed. A biotinylated nanodisc can support streptavidin-based immobilization with controlled capture, provided the biotinylation design and assay orientation preserve the antibody or ligand-binding site. Direct passive adsorption may be suitable for some ELISA workflows, although it can produce less controlled orientation. For SPR or BLI, select the sensor chemistry, immobilized partner and surface density before choosing the protein format.

Review product-specific activity

“Active” should be interpreted using the test shown on the individual product page. Antibody-binding ELISA supports epitope presentation in that configuration. SPR or BLI affinity data provide additional evidence for a documented interaction, but the numerical value can change with antibody format, immobilization level, mass transport, buffer and fitting model. A ligand-binding study requires evidence relevant to the ligand or interaction being investigated. Antibody-binding validation alone does not guarantee that every small molecule, peptide or native ligand will bind detectably.

Confirm formulation, storage and handling requirements

Before ordering, review the product’s formulation, physical form, endotoxin specification, shipping condition, recommended storage temperature and freeze–thaw guidance. Confirm that the supplied buffer is compatible with the planned sensor surface, labeling method and downstream assay. Request current concentration, available quantity and product documentation through the individual product inquiry form.

Using GPCR Nanodiscs in Antibody-Discovery Workflows

GPCR nanodisc proteins can be integrated at several stages of an antibody program:

1. Primary binding screen: identify clones that recognize the membrane-supported receptor.
2. Counter-screen: test binding against an empty or target-free nanodisc, scaffold component and unrelated membrane protein.
3. Specificity panel: compare related receptors, isoforms or species using aligned formats.
4. Kinetic characterization: evaluate selected antibodies by SPR or BLI with a compatible capture design.
5. Orthogonal confirmation: confirm binding on receptor-expressing cells and assess functional effects where required.

Include target-free nanodisc controls whenever feasible. Antibodies can bind the scaffold, lipid components, tag or another non-target feature. A tag-matched unrelated nanodisc also helps separate receptor-specific binding from format-related signal. For therapeutic-antibody discovery, use nanodisc results as one part of a staged evidence package. Cell-surface binding, species cross-reactivity, competition, signaling, internalization and effector-function studies may require separate assay systems.

GPCR Nanodiscs for Ligand-Binding Assays

The appropriate ligand-binding workflow depends on the ligand class and expected affinity. Antibodies and larger protein ligands can often be assessed using ELISA, SPR or BLI. Small-molecule GPCR ligands may require specialized detection, competition or label-free methods because their low molecular mass can limit direct response.

High surface density can create avidity or rebinding effects, especially with bivalent antibodies. Run a loading-density series during method development and use an orthogonal configuration when a binding result will guide major clone-selection decisions.

Why Source GPCR Nanodisc Proteins from Beta LifeScience?

Beta LifeScience’s nanodisc transmembrane protein collection includes GPCRs and other multi-pass membrane targets in membrane-mimetic formats. The catalog provides human targets, mammalian-expression formats, His-tagged products and selected biotinylated nanodiscs, with product-specific binding data where listed.

Researchers can use the catalog route for an established target or request technical evaluation for:

• another GPCR subtype, ortholog, isoform or mutation;
• His, Flag, biotinylated or project-specific tag design;
• an assay-oriented capture configuration;
• antibody-binding, ligand-binding or kinetic validation;
• alternative quantity, concentration or formulation requirements; and
• coordinated panels containing multiple GPCRs or species.

Beta LifeScience’s membrane protein production in nanodiscs service provides a route for new target development. The broader transmembrane protein expression service can also help researchers evaluate nanodisc, VLP, detergent-solubilized or cell-free approaches according to the planned application. Feasibility, validation scope, quantity, lead time and pricing remain project-specific.

Choose a Catalog or Custom Nanodisc Route

Information to Include in a GPCR Nanodisc Quote Request

Provide a quote-ready project specification:

1. target name, species and UniProt accession;
2. isoform, mutation and required sequence;
3. antibody epitope or ligand-binding region, if known;
4. antibody or ligand format;
5. ELISA, SPR, BLI or other assay platform;
6. planned immobilization and detection strategy;
7. preferred tag, tag position and biotinylation requirement;
8. required quantity, concentration, formulation and QC; and
9. project schedule and delivery requirements.

Submitting the assay design with the target specification helps determine whether an existing product is suitable or whether another nanodisc configuration should be evaluated.

FAQs

Are GPCR nanodisc proteins suitable for antibody screening?

They can support screening for antibodies that recognize membrane-associated or conformational GPCR epitopes. Include target-free nanodisc and unrelated membrane-protein controls, then confirm promising antibodies using a suitable cell-based method.

Can GPCR nanodiscs be used in SPR and BLI?

Yes, when the product format, capture chemistry, buffer and immobilization level are compatible. Review product-specific validation rather than assuming every nanodisc is qualified for every instrument configuration.

Should I choose a His-tagged or biotinylated GPCR nanodisc?

Choose according to the planned capture surface. His-tagged formats may suit compatible metal-chelate capture, while biotinylated formats can support streptavidin-based immobilization. Tag accessibility and epitope orientation should be considered in both cases.

Do nanodisc assays prove functional GPCR antagonism?

Not by themselves. A biochemical competition assay can show disruption of a defined interaction, while functional antagonism may require receptor signaling, internalization or another cell-based endpoint.

Can Beta LifeScience develop a custom GPCR nanodisc?

Custom nanodisc production can be submitted for technical evaluation. Provide the sequence, desired format, assay application, validation needs and quantity so feasibility and quotation requirements can be reviewed.

Compare GPCR Nanodisc Formats for Your Assay

Compare catalog GPCR nanodiscs by receptor sequence, tag, biotinylation status, documented activity and immobilization compatibility. If a listed format matches the assay, use its product inquiry form for current ordering information. For another target, species, construct or capture strategy, submit the complete requirements for custom technical evaluation and quotation.

Compare GPCR and Nanodisc Proteins
Request a Custom GPCR Nanodisc Quote